A Trial Comparing the Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Subjects With Type 2 Diabetes Mellitus (BEGIN COMPARE)
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Insulin degludec (Primary) ; Alpha-glucosidase inhibitors; CD26 antigen inhibitors; Metformin; Pioglitazone; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms BEGIN; BEGIN-COMPARE
- 07 Jun 2017 Biomarkers information updated
- 18 Jan 2012 Actual patient number (373) added as reported by ClinicalTrials.gov.
- 18 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.